What OEM means in diagnostics
An IVD OEM arrangement is a supply relationship in which the company whose brand appears on the box is not the company that developed or manufactured the chemistry inside it. The buyer-side company (the brand owner) gains a product line without building production; the OEM manufacturer gains volume without building a sales channel. The arrangement is common across clinical chemistry, immunoassay and rapid-test formats, and it is a normal part of the industry rather than a corner case.
OEM, white-label, private label and distribution
Four arrangements are often conflated. A distributor resells the manufacturer's product, usually under the manufacturer's brand, and adds logistics and service. White-label means the OEM's finished product is rebranded and sold largely as-is. Private label is functionally similar but usually implies the brand owner specifies packaging, menu or configuration. Full OEM or co-development means the product (or platform) is designed or adapted for the partner and may be exclusive. The differences that matter contractually are who holds design documentation, who holds regulatory approval, and what is exclusive.
The regulatory holder is the deal
The single most consequential clause in an IVD OEM contract is who is the legal manufacturer in the regulatory sense. In the EU, the legal manufacturer under the IVDR owns the technical documentation, performance evaluation, post-market surveillance and vigilance reporting; transferring that role to the brand owner requires them to take on those obligations, and the transition deadline regime for legacy devices (running through 2027–2028 by risk class) can constrain re-timing. In the US, the 510(k) holder is the FDA-regulated sponsor of the clearance. Distributor-only deals avoid this transfer; rebranding deals cannot.
Deal structure checklist
Before term-sheet stage, settle: (1) scope — which products, configurations and catalogue numbers; (2) regulatory role — who is legal manufacturer, who holds certificates, who files changes; (3) exclusivity — by market, product line and duration; (4) economics — per-test or per-kit pricing, volume tiers, minimum commitments; (5) supply continuity — lead times, safety stock, last-buy terms; (6) change control — how formulation or packaging changes are notified and who approves them. Every one of these has sunk a deal that started as a friendly sample exchange.
How to shortlist OEM-capable manufacturers
Directories that declare business types make the first cut faster. IVDmap company profiles carry explicit "OEM / ODM" and "CDMO / Private Label" badges alongside the standard manufacturer and distributor types, each profile lists the product records counted from its live catalogue (about 1,500 records across roughly 150 manufacturers as of November 2026), and regulatory labels are shown as manufacturer-reported rather than verified. Shortlist by declared capability and product-family fit, then verify capability the same way you would for any purchase: certificates, references, and a pilot order.
